On Thursday, Shares of Rovi Corporation (NASDAQ:ROVI), gained 3.81% to $11.71.
Rovi Corporation, released findings from a sponsored survey of pay-TV and over-the-top (OTT) content subscribers in the U.S., Europe, and Asia. The global study aimed to uncover trends in viewer behavior related to discovery, search, and recommendations for entertainment content and programming.
Rovi Corporation provides integrated solutions for the discovery and personalization of digital entertainment to service providers and consumer electronics (CE) industry worldwide.
Shares of Viavi Solutions Inc (NASDAQ:VIAV), declined -0.90% to $5.51, during its last trading session.
Viavi Solutions Inc., declared it is expanding its portfolio of software-defined network test and monitoring solutions with the new GigaStor Software Edition to manage performance and user experience in virtual and cloud environments. The new software configurations, which Viavi is demonstrating at VMworld, allow network and server teams to capture and save 250 GB or 1 TB of continuous traffic to disk for in-depth performance and forensic analysis.
“IT teams are wasting a lot of time by only tracking virtual server and resource health,” said Charles Thompson, senior director of product administration, Viavi Solutions. “These teams can often miss problems associated with applications within the hypervisor with such narrow vision. With GigaStor Software engineers now have the ability to see in real time and historically how users are experiencing applications and services within the virtual environment, saving time and end-user heartache.”
Viavi Solutions Inc. engages in the network enablement, service enablement, and communications and commercial optical products businesses. The company’s Network Enablement segment provides an integrated portfolio of testing solutions that access the network to perform build out and maintenance tasks.
At the end of Thursday’s trade, Shares of Avis Budget Group Inc. (NASDAQ:CAR), gained 0.11% to $44.05.
Avis Budget Group, declared that Avis Car Rental and Budget Car Rental customers can now purchase smartphone dash mounts. Available at participating locations across the United States, the new phone accessory is a robust sticky pad with side walls to hold items such as smartphones and GPS units securely.
“As a company that is committed to the safety of its customers, we encourage renters to keep their eyes on the road, their hands on the steering wheel, and distractions to a minimum,” said Joe Ferraro, president, Americas, Avis Budget Group. “The new smartphone dash mounts will assist customers focus on driving so as to make the trip as stress-free and enjoyable as possible.”
The products are available at Avis and Budget rental facilities across America’s top airports, counting Atlanta, Boston, Chicago, Dallas, Denver, Fort Lauderdale, Jacksonville, Los Angeles, Honolulu, Houston, Miami, New York, Orlando, Philadelphia, Phoenix, San Diego and San Francisco. The accessory is also available at select off-airport locations.
Avis Budget Group, Inc., together with its auxiliaries, provides car and truck rentals, car sharing, and ancillary services to businesses and consumers worldwide. The company has three segments: North America, International, and Truck Rental.
Finally, Horizon Pharma PLC (NASDAQ:HZNP), ended its last trade with 0.53% gain, and closed at $28.58.
Horizon Pharma plc, declared that it has commenced mailing solicitation materials to Depomed, Inc. shareholders, counting a definitive solicitation statement formerly filed with the U.S. Securities and Exchange Commission on September 8, 2015 and a special letter, in connection with Horizon Pharma’s efforts to call two related special meetings of Depomed shareholders.
As formerly declared, on September 8, 2015, Horizon Pharma has also separately commenced an exchange offer to acquire all issued and outstanding shares of Depomed common stock. Under the terms of the exchange offer, each holder of Depomed common stock will have the right to receive 0.95 Horizon Pharma ordinary shares for each of their Depomed shares, which exchange ratio was based on a $33.00 per share offer price for Depomed stock and 15-day volume weighted average price of Horizon Pharma ordinary shares as of August 12th, 2015 of $34.74. The exchange offer, however, is conditioned on, among other things, the withdrawal or invalidation of Depomed’s poison pill noted below.
A copy of Horizon Pharma’s solicitation statement and special letter, in addition to the documents related to the exchange offer, are viewable at: www.HorizonAndDepomed.com, a website that Horizon Pharma launched to provide details and other relevant information regarding its proposals for the special meetings.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
